CHARACTERIZATION OF [H-3] CERANAPRIL RECOGNITION SITES IN RAT AND HUMAN BRAIN-TISSUE

被引:7
作者
BARNES, NM
COSTALL, B
EGLI, P
HOROVITZ, ZP
IRONSIDE, JW
NAYLOR, RJ
WILLIAMS, TJ
机构
[1] UNIV BRADFORD,SCH PHARM,BRADFORD BD7 1DP,W YORKSHIRE,ENGLAND
[2] UNIV LEEDS,DEPT PATHOL,LEEDS LS2 9JT,W YORKSHIRE,ENGLAND
[3] SQUIBB INST MED RES,PRINCETON,NJ 08540
关键词
H-3]CERANAPRIL; BRAIN; ANGIOTENSIN CONVERTING ENZYME; RAT; HUMAN;
D O I
10.1016/0028-3908(91)90126-V
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The present studies assessed the nature of the recognition site for [H-3]ceranapril in tissue from rat and human brain. [H-3]Ceranapril exhibited high affinity saturable specific (defined by 1-mu-M captopril) binding to homogenates of tissue from both rat and human brain (mean pK(d) values between 8.42 and 8.69). High binding densities were observed in rat striatum and homogenates of tissue from human caudate (B(max) values 3317 +/- 192 and 1900 +/- 110 fmol/mg protein respectively), with comparatively low densities in cortical tissues. In kinetic experiments, association of [H-3]ceranapril to homogenates of rat and human cortex was found to be rapid and fully reversible (K+1 = 6 x 10(5) M-1 sec-1 and 2.4 x 10(6) M-1 sec-1, K-1 = 7.6 x 10(-3) sec-1 and 4.5 x 10(-3) sec-1 respectively). In competition studies, lisinopril, captopril, unlabelled ceranapril, epicaptopril and fosinopril, all competed to a similar extent and with similar rank order of potency for the binding of [H-3]ceranapril to homogenates of both rat and human brain. In in vivo studies, pretreatment of rats with either captopril or lisinopril (15-mu-g/250 g) significantly reduced the content of tritium in brain, as measured 20 min after intravenous administration of [H-3]ceranapril. From these experiments [H-3]ceranapril appears to selectively label, with high affinity, the inhibitor binding site of angiotensin converting enzyme and this site appears to be similar in both species studied.
引用
收藏
页码:907 / 914
页数:8
相关论文
共 28 条
[1]   ANGIOTENSIN-II INHIBITS THE RELEASE OF [H-3]ACETYLCHOLINE FROM RAT ENTORHINAL CORTEX INVITRO [J].
BARNES, JM ;
BARNES, NM ;
COSTALL, B ;
HOROVITZ, ZP ;
NAYLOR, RJ .
BRAIN RESEARCH, 1989, 491 (01) :136-143
[2]   ANGIOTENSIN-II INHIBITS ACETYLCHOLINE-RELEASE FROM HUMAN TEMPORAL CORTEX - IMPLICATIONS FOR COGNITION [J].
BARNES, JM ;
BARNES, NM ;
COSTALL, B ;
HOROVITZ, ZP ;
IRONSIDE, JW ;
NAYLOR, RJ ;
WILLIAMS, TJ .
BRAIN RESEARCH, 1990, 507 (02) :341-343
[3]   THE CHOLINERGIC HYPOTHESIS OF GERIATRIC MEMORY DYSFUNCTION [J].
BARTUS, RT ;
DEAN, RL ;
BEER, B ;
LIPPA, AS .
SCIENCE, 1982, 217 (4558) :408-417
[4]   CO-IDENTITY OF BRAIN ANGIOTENSIN CONVERTING ENZYME WITH A MEMBRANE-BOUND DIPEPTIDYL CARBOXYPEPTIDASE INACTIVATING MET - ENKEPHALIN [J].
BENUCK, M ;
MARKS, N .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1979, 88 (01) :215-221
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]   PEPTIDYL DIPEPTIDASE IN RABBIT BRAIN MICROVESSELS [J].
BRECHER, P ;
TERCYAK, A ;
GAVRAS, H ;
CHOBANIAN, AV .
BIOCHIMICA ET BIOPHYSICA ACTA, 1978, 526 (02) :537-546
[7]   ANGIOTENSIN CONVERTING ENZYME IN THE HUMAN BASAL FOREBRAIN AND MIDBRAIN VISUALIZED BY INVITRO AUTORADIOGRAPHY [J].
CHAI, SY ;
MCKENZIE, JS ;
MCKINLEY, MJ ;
MENDELSOHN, FAO .
JOURNAL OF COMPARATIVE NEUROLOGY, 1990, 291 (02) :179-194
[8]   DEGRADATION OF NEUROTENSIN BY RAT-BRAIN SYNAPTIC-MEMBRANES - INVOLVEMENT OF A THERMOLYSIN-LIKE METALLOENDOPEPTIDASE (ENKEPHALINASE), ANGIOTENSIN-CONVERTING ENZYME, AND OTHER UNIDENTIFIED PEPTIDASES [J].
CHECLER, F ;
VINCENT, JP ;
KITABGI, P .
JOURNAL OF NEUROCHEMISTRY, 1983, 41 (02) :375-384
[9]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[10]   EFFECTS OF CAPTOPRIL AND SQ29,852 ON ANXIETY-RELATED BEHAVIORS IN RODENT AND MARMOSET [J].
COSTALL, B ;
DOMENEY, AM ;
GERRARD, PA ;
HOROVITZ, ZP ;
KELLY, ME ;
NAYLOR, RJ ;
TOMKINS, DM .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 36 (01) :13-20